Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) Equity Ratio (2016 - 2026)

Biomerica's Equity Ratio history spans 16 years, with the latest figure at 0.68 for Q1 2026.

  • Quarterly results put Equity Ratio at 0.68 for Q1 2026, down 9.37% from a year ago — trailing twelve months through Feb 2026 was 0.68 (down 9.37% YoY), and the annual figure for FY2025 was 0.69, down 3.05%.
  • Equity Ratio for Q1 2026 was 0.68 at Biomerica, down from 0.74 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.81 in Q3 2023 to a low of 0.56 in Q1 2022.
  • The 5-year median for Equity Ratio is 0.73 (2022), against an average of 0.73.
  • The sharpest move saw Equity Ratio tumbled 30.03% in 2022, then surged 31.25% in 2023.
  • Year by year, Equity Ratio stood at 0.73 in 2022, then increased by 8.47% to 0.79 in 2023, then decreased by 11.35% to 0.7 in 2024, then rose by 4.54% to 0.74 in 2025, then fell by 7.48% to 0.68 in 2026.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.68, 0.74, and 0.75 for Q1 2026, Q4 2025, and Q3 2025 respectively.